文献速递肝病消化道肿瘤与早癌

乙型和丙型肝炎的晚期诊断与疾病失代偿及肝细胞癌发生的关系

Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.
PubMed 文献 · J Hepatol · 2017-07-04

研究分析了1990至2012年乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)诊断相对于失代偿期肝硬化(DC)和肝细胞癌(HCC)检测的时间,发现HBV和HCV合并DC者中分别有49%和40%为晚期诊断,合并HCC者中分别有46%和31%为晚期诊断,晚期诊断比例随时间下降,并与较少就医次数和精神疾病相关。

要点

  • 在发生DC的HBV和HCV病例中,分别有49%和40%为晚期诊断;在发生HCC的病例中,分别有46%和31%为晚期诊断。
  • HBV晚期诊断比例从1992年的100%降至2011年的11%(DC)和26%(HCC)。
  • HCV晚期诊断比例从1992年的100%降至2011年的16%(DC)和14%(HCC)。

核心结论

  • 晚期诊断的比例随时间下降;与医疗系统接触更好和有风险行为的人群更早被诊断。

研究设计与样本

  • 研究纳入1990至2012年32,664例HBV病例和57,866例HCV病例,采用多变量逻辑回归评估与晚期诊断相关的因素。

主要发现

  • 778/32,664例HBV病例(2.4%)和3,925/57,866例HCV病例(6.8%)发生DC;628/32,644例HBV病例(1.9%)和902/57,866例HCV病例(1.6%)发生HCC。
  • 在发生DC的HBV和HCV病例中,分别有49%和40%为晚期诊断;在发生HCC的HBV和HCV病例中,分别有46%和31%为晚期诊断。
  • HBV晚期诊断比例从1992年的100%降至2011年的11%(DC)和26%(HCC);HCV晚期诊断比例从1992年的100%降至2011年的16%(DC)和14%(HCC)。
  • 多变量模型显示,晚期HBV诊断与精神疾病及诊断前5年内就医次数较少相关;晚期HCV诊断也与就医次数较少相关,而有非法药物使用史者更少被晚期诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We measured the timing of hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnoses relative to the detection of decompensated cirrhosis (DC) and hepatocellular carcinoma (HCC) as an indicator of late hepatitis diagnosis. METHODS: HBV and HCV diagnoses were defined relative to the diagnosis of DC or HCC such that HBV/HCV diagnoses within two years prior, at the time of or after HCC or DC diagnosis were considered late. We performed multivariable logistic regression to assess factors associated with late HBV/HCV diagnoses among those with DC or HCC. RESULTS: From 1990 to 2012, 778/32,664 HBV cases (2.4%) and 3,925/57,866 HCV cases (6.8%) developed DC while 628/32,644 HBV cases (1.9%) and 902/57,866 HCV cases (1.6%) developed HCC. Among HBV and HCV cases with DC, 49% and 40% respectively were late diagnoses, as were 46% and 31% of HBV and HCV cases with HCC, respectively. HBV late diagnosis declined from 100% in 1992 to 11% and 26% in 2011, while HCV late diagnosis declined from 100% in 1992 to 16% and 14% in 2011 for DC and HCC respectively. In multivariable modelling, late HBV diagnosis was associated with mental illness and a fewer number of physician visits in the five years prior to HBV diagnosis. Late HCV diagnosis was also associated with fewer physician visits, while those with illicit drug use were less likely to be diagnosed late. CONCLUSIONS: The proportion of late diagnoses has declined over time. People with better engagement with the healthcare system and with risk activities were diagnosed earlier. Lay summary: Late diagnosis of HBV and HCV represents a missed opportunity to reduce the risk of serious liver disease. Our results identify successes in earlier diagnosis over time using risk-based testing as well as groups that are being missed for screening such as those who do not see a physician regularly and those with serious mental illness.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Samji H, Yu A, Kuo M, et al. Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development. J Hepatol. 2017. PMID: 28684103. doi:10.1016/j.jhep.2017.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。